US EditionAmorepacific and Johns Hopkins School of Medicine's Joint Research Program 'NBRI' Participants Present Latest Findings
- Participants in Amorepacific and Johns Hopkins School of Medicine's NBRI program presented their latest findings at the 2025 SID Annual Meeting in San Diego, California.
- The NBRI program, started in 2022, is a joint collaboration between Amorepacific and Johns Hopkins' Department of Dermatology focused on skin longevity research.
- Professor Anna Chien's team showed that Amorepacific's RE.D Flavonoid, derived from camellia, improves photo-aging signs like fine lines and pigmentation without irritation over six months in diverse North American consumers.
- Professor Martin Alphonse's team demonstrated that Senomune, a green tea-based saponin, reduces immune cell and inflammatory damage caused by particulate matter and may help lower immune aging and chronic inflammation.
- Dr. Suh Byung-fhy, Amorepacific CTO, emphasized that the NBRI program highlights their slow-aging skincare technology and that future research will target skin recovery beyond symptom relief.
Insights by Ground AI
Does this summary seem wrong?
29 Articles
29 Articles
All
Left
2
Center
14
Right
1
Coverage Details
Total News Sources29
Leaning Left2Leaning Right1Center14Last UpdatedBias Distribution82% Center
Bias Distribution
- 82% of the sources are Center
82% Center
12%
C 82%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
